Evidence map›Paper›PMID 27631996›Full record

ArticleJournal of religion and health2017

Barriers to Cancer Clinical Trial Participation Among Saudi Nationals: A Cross-Sectional Study.

Khalid M Almutairi, Wadi B Alonazi, Abdulaziz A Alodhayani, Jason M Vinluan, Mahaman Moussa, Abdulrahman S Al-Ajlan, Khalid Alsaleh, Duna Alruwaimi, Nader E Alotaibi

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of religion and health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Khalid M AlmutairiDepartment of Community Health Science, College of Applied Medical Science, King Saud University, Riyadh, Saudi Arabia. Kalmutairim@ksu.edu.sa.
Wadi B AlonaziCollege of Business Administration, King Saud University, Riyadh, Saudi Arabia.
Abdulaziz A AlodhayaniDepartment of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Jason M VinluanDepartment of Community Health Science, College of Applied Medical Science, King Saud University, Riyadh, Saudi Arabia.
Mahaman MoussaMedical Surgical Department, College of Nursing, King Saud University, Riyadh, Saudi Arabia.
Abdulrahman S Al-AjlanClinical Laboratories Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Khalid AlsalehCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Duna AlruwaimiClinical Laboratories Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Nader E AlotaibiCollege of Business Administration, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to determine the factors that act as barriers to Saudi cancer patients in participating in a clinical trial (CT). A total of 244 patients from two different tertiary level hospitals (King Khalid University Hospital and King Fahad Medical City Hospital) in Riyadh, Saudi Arabia, participated in this cross-sectional study. The participants were interviewed by a trained researcher between September and November 2015. All respondents answered a three-part questionnaire which includes demographics, clinical information, and questions related to awareness of CTs, willingness to participate, and factors affecting participation in CTs. The mean age of the participants was 50.83, and 57 % of the participants were females. Most of the participants (63.5 %) were currently being treated for cancer, and 28 % were diagnosed with breast cancer followed by colorectal cancer. Health status or quality of life was self-reported as acceptable by 27.9 % of the participants, and 25 % of the participants at stage II of cancer. The factors that act as barriers to Saudi cancer patients in participating in a CT can be categorized into patient- and physician-related factors. Patient factors include lack of awareness, misconception and fear in participating in CTs; physician-related factors comprise of lack of encouragement from physician to patients in participating in a CT. The study identified few major barriers to participation in CTs. Increased patient awareness and recruitment strategies are required to increase accrual of patients including training for physicians and disseminating easy-to-read tools to the public.

Indexed as

Health Knowledge, Attitudes, PracticeAdultAgedAged, 80 and overClinical Trials as TopicCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeoplasmsResearch SubjectsSaudi ArabiaBarriersCancer clinical trialsPatient accrualSaudi Arabia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.